These effects, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the strategy of targeting ACKR3 as a singular approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. Publishing this review implies that https://elleryh383nqn1.wikigop.com/user